Clinical Trials in Detroit

Showing 8101-8120 of 19,719 trials

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

NCT00463554

The primary objective of this study is to obtain clinical performance information on the GYNECARE TVT-SECUR\* System (Tension-free Support for Incontinence) in women with stress urinary incontinence (SUI).

Stress Urinary Incontinence

Ethicon, Inc.72 participantsStarted Apr 2006

Dearborn, Michigan, United States • Cincinnati, Ohio, United States • Allentown, Pennsylvania, United States +3 more locations

COMPLETEDPhase 336 miles

Maximizing Outcomes in Treating Acute Migraine

NCT03896009

AXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in adults. AXS-07 tablets are formulated to provide an enhanced rate of absorption of meloxicam. This study is designed to evaluate the efficacy and safety of AXS-07 compared to meloxicam, rizatriptan, and placebo for the treatment of a migraine attack. This is a randomized, double-blind, 4-arm, parallel group, single-dose, placebo-controlled trial. Subjects who successfully complete screening and continue to meet all entry criteria will be randomly assigned to take one dose of either AXS-07, meloxicam, rizatriptan, or placebo upon the occurrence of a qualifying migraine.

Migraine

Axsome Therapeutics, Inc.1,594 participantsStarted Mar 2019

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +82 more locations

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

Maximizing Outcomes in Treating Acute Migraine

Find Trials by Condition in Detroit

BioVentrix Revivent TC™ System Clinical Study

Study of Sargramostim in Patients With COVID-19

Safety and Tolerability of Repeat Courses of IM Alefacept

Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Pilot Clinical Performance of a Silicone Hydrogel Lens for Up to Six Nights of Extended Wear

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

A Dose Finding Study to Treat Bone Tumor(s)

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome